- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2015
- Public Summary Document (PSD) November 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2015 PBAC Meeting - Word
Omalizumab – November 2015
Omalizumab: pre-filled syringe, 150 mg/mL, Xolair®
Last updated
4 March 2016